Target intelligence / Profile preview

Ankyrin repeat and SOCS box protein 3 (ASB3)

Target
ASB3
Molecular classification
Other (SOCS box protein superfamily), E3 ubiquitin-protein ligase complex component, Protein-binding adaptor
01

Overview

Ankyrin repeat and SOCS box protein 3 (ASB3) is an intracellular protein composed of an N-terminal ankyrin repeat region (typically 11–12 repeats) and a C-terminal SOCS box domain. ASB3 acts as the substrate recognition component in ECS-type cullin-RING E3 ubiquitin ligase complexes, facilitating the ubiquitination and proteasomal degradation of target proteins, most notably tumor necrosis factor receptor 2 (TNF-R2). By promoting the breakdown of TNF-R2, ASB3 negatively regulates the JNK signaling pathway and apoptosis in response to TNF-α, as well as influencing other cell signaling and immune processes. ASB3 is implicated as a negative regulator of inflammatory signaling, a modulator in cancer biology, and possibly involved in other disease processes. There are no clinically approved drugs or validated biomarkers directly targeting ASB3 currently reported.

Other names
ASB3Ankyrin repeat and SOCS box containing 3ASB-3GPR75-ASB3ankyrin repeat and SOCS box protein 3
02

Mechanism of action

Inhibition of TNF-R2-mediated cell signaling via substrate-targeted ubiquitination and degradation; Regulation of antiviral and inflammatory pathways by mediating degradation of MAVS and TRAF6

03

Biological functions

Ubiquitination of target proteinsProtein degradation via the proteasome pathwayNegative regulation of signal transduction (especially TNF-R2/JNK pathway)Down-regulation of antiviral innate immunity
04

Disease associations

Cancer (associated with colorectal cancer pathogenesis and pan-cancer studies)Inflammation (regulation of TNF-R2 relevant for inflammatory responses)Neurodegenerative disease (risk associations mentioned)

Beyond the preview

Go deeper on Ankyrin repeat and SOCS box protein 3 (ASB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and SOCS box protein 3 (ASB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call